These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23593984)

  • 1. A targeted method for standardized assessment of adverse drug events in surgical patients.
    de Boer M; Kiewiet JJ; Boeker EB; Ramrattan MA; Dijkgraaf MG; Lie-A-Huen L; Boermeester MA;
    J Eval Clin Pract; 2013 Dec; 19(6):1073-82. PubMed ID: 23593984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients.
    Kunac DL; Reith DM; Kennedy J; Austin NC; Williams SM
    Qual Saf Health Care; 2006 Jun; 15(3):196-201. PubMed ID: 16751470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.
    Hébert G; Netzer F; Kouakou SL; Lemare F; Minvielle E;
    Int J Clin Pharm; 2018 Apr; 40(2):376-385. PubMed ID: 29446003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
    Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
    Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy.
    Klopotowska JE; Wierenga PC; Stuijt CC; Arisz L; Dijkgraaf MG; Kuks PF; Asscheman H; de Rooij SE; Lie-A-Huen L; Smorenburg SM;
    PLoS One; 2013; 8(8):e71045. PubMed ID: 23940688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for assessing the preventability of adverse drug events: a systematic review.
    Hakkarainen KM; Andersson Sundell K; Petzold M; Hägg S
    Drug Saf; 2012 Feb; 35(2):105-26. PubMed ID: 22201475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detecting adverse drug events during the hospital stay].
    Berga Culleré C; Gorgas Torner MQ; Altimiras Ruiz J; Tuset Creus M; Besalduch Martín M; Capdevila Sunyer M; Torres Gubert M; Casajoana Cortinas MT; Baró Sabaté E; Fernández Solà JR; Moron i Besolí A; Odena Estradé E; Serrais Benavente J; Vitales Farrero MT; Codina Jané C
    Farm Hosp; 2009; 33(6):312-23. PubMed ID: 20038390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing a trigger tool as a method of detecting harm from medication errors in a UK hospital: a pilot study.
    Franklin BD; Birch S; Schachter M; Barber N
    Int J Pharm Pract; 2010 Oct; 18(5):305-11. PubMed ID: 20840687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study.
    Benkirane RR; Abouqal R; Haimeur CC; S Ech Cherif El Kettani SS; Azzouzi AA; Mdaghri Alaoui AA; Thimou AA; Nejmi MM; Maazouzi WW; Madani NN; R-Edwards I; Soulaymani RR
    J Patient Saf; 2009 Mar; 5(1):16-22. PubMed ID: 19920434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Adverse Drug Event Collaborative: a joint venture to measure medication-related patient harm.
    Seddon ME; Jackson A; Cameron C; Young ML; Escott L; Maharaj A; Miller N
    N Z Med J; 2012 Jan; 126(1368):9-20. PubMed ID: 23385830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.
    Iftikhar S; Sarwar MR; Saqib A; Sarfraz M
    PLoS One; 2018; 13(6):e0199456. PubMed ID: 29949616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
    Kunac DL; Kennedy J; Austin N; Reith D
    Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
    Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
    JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability evaluation of the adapted national coordinating council medication error reporting and prevention (NCC MERP) index.
    Snyder RA; Abarca J; Meza JL; Rothschild JM; Rizos A; Bates DW
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1006-13. PubMed ID: 17523185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).
    Klopotowska JE; Wierenga PC; de Rooij SE; Stuijt CC; Arisz L; Kuks PF; Dijkgraaf MG; Lie-A-Huen L; Smorenburg SM;
    BMC Health Serv Res; 2011 May; 11():124. PubMed ID: 21612624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of the assessment of preventable adverse drug events in daily clinical practice.
    van Doormaal JE; Mol PG; van den Bemt PM; Zaal RJ; Egberts AC; Kosterink JG; Haaijer-Ruskamp FM
    Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):645-54. PubMed ID: 18338767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug events and medication errors: detection and classification methods.
    Morimoto T; Gandhi TK; Seger AC; Hsieh TC; Bates DW
    Qual Saf Health Care; 2004 Aug; 13(4):306-14. PubMed ID: 15289635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct observation approach for detecting medication errors and adverse drug events in a pediatric intensive care unit.
    Buckley MS; Erstad BL; Kopp BJ; Theodorou AA; Priestley G
    Pediatr Crit Care Med; 2007 Mar; 8(2):145-52. PubMed ID: 17273111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.